Data Collection on ReCap/Magnum in Total Hip Replacement and Resurfacing

Zimmer Biomet150 enrolled

Overview

Observational study on ReCap/Magnum in Total Hip Replacement and Resurfacing.

This observational study intends to collect efficacy and safety data on ReCap/Magnum in Total Hip Replacement and Resurfacing.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Total Hip Resurfacing

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Consecutive series of patients received Total Hip Replacement or Resurfacing with ReCap/Magnum for Its Respective Indications for Use/Intended Uses

Locations (6)

CHU Amiens

Amiens, France

CHU Pellegrin Tripode

Bordeaux, France

CHU Hôpital Sud

Grenoble, France

Polyclinique de Hénin Beaumont

Hénin-Beaumont, France

Polyclinique de Riaumont

Outcomes

Primary Outcomes

Postel-Merle d'Aubigné (PMA), Harris Hip Score

Time frame: 1yr and 2yr

Secondary Outcomes

Complication

Time frame: Any time

Survival

Time frame: 1yr and 2yr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.